FDA Requires Black Box Update For Risks Of Benzodiazepines

Mealey's (October 14, 2020, 9:29 AM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on Sept. 23 issued a Drug Safety Communication that it is requiring manufacturers of benzodiazepines to update the black box warnings for that class of drugs for their risk of abuse, misuse, addiction, physical dependence and withdrawal reactions....

Related Sections